![Kenneth Mulvany](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth Mulvany
Director/Board Member at BENEVOLENTAI
Network origin in Kenneth Mulvany first degree
Entity | Entity type | Industry | |
---|---|---|---|
27
| Public Company | Biotechnology | 27 |
BenevolentAI Bio Ltd.
![]() BenevolentAI Bio Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Bio Ltd. is a clinical-stage AI-enabled drug discovery and British development company founded in 2013. The company is based in London, UK. BenevolentAI Bio uses AI to augment scientific ingenuity in the drug discovery process, from target identification to clinical development, with the goal of improving the probability of clinical success. The company has refined and formalized its approach to sustainability under the direction of the newly established environmental, social, and governance (ESG) governance structure and teams. BenevolentAI Bio's AI-enabled Benevolent Platform™ empowers scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.
1
| Subsidiary | Packaged Software | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kenneth Mulvany via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
ROYAL BANK OF CANADA | Major Banks | Corporate Officer/Principal | |
Natixis Investment Managers LP
![]() Natixis Investment Managers LP Investment ManagersFinance Natixis Investment Managers LP engages in the provision of investment management solutions. Its investments focused on the mutual funds, exchange traded funds, target date funds, retirement, separate accounts, and wealth management. The company was founded in 1997 and is headquartered in Boston, MA. | Investment Managers | Chief Executive Officer | |
ATKINSRÉALIS GROUP INC. | Engineering & Construction | Director/Board Member | |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Director of Finance/CFO | |
CANADIAN CONVERTIBLES PLUS FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
CRESCENT SENIOR SECURED FLOATING RATE LOAN FUND, LLC | Investment Trusts/Mutual Funds | Director/Board Member | |
BAXALTA INC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
Sullivan & Cromwell LLP
![]() Sullivan & Cromwell LLP Miscellaneous Commercial ServicesCommercial Services Sullivan & Cromwell LLP provides legal services. It specializes in the areas of corporate law, securities, corporate, litigation, mergers, real estate, pro bono, investment management and taxation. Their clients include industrial, commercial, financial, private funds, governmental, educational, charitable and cultural enterprises and entities. The company was founded by Algernon Sydney Sullivan and William Nelson Cromwell in 1879 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Cambridge | College/University | Graduate Degree | |
BenevolentAI Cambridge Ltd.
![]() BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Oddo BHF SCA
![]() Oddo BHF SCA Investment ManagersFinance Oddo BHF SCA engages in the investment banking and capital management activities. It operates in the following business segments; Privates wealth management, Asset management, Corporates & markets and, Account safekeeping & custodial services. The company was founded by Camille Gautier in 1849 and is headquartered in Paris, France. | Investment Managers | Director/Board Member | |
University of Bristol | College/University | Graduate Degree Graduate Degree | |
Agency for Science, Technology & Research
![]() Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
Idis Ltd.
![]() Idis Ltd. Drugstore ChainsRetail Trade Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom | Drugstore Chains | Director/Board Member | |
Université Laval | College/University | Graduate Degree | |
Royal Holloway University of London | College/University | Doctorate Degree | |
University of Aston | College/University | Graduate Degree | |
Goldman Sachs, Inc. et Cie.
![]() Goldman Sachs, Inc. et Cie. Investment Banks/BrokersFinance Founded in 1987, part of The Goldman Sachs Group, Inc., Goldman Sachs, Inc. et Cie. provides brokerage services. The company is based in Paris, France. | Investment Banks/Brokers | Chief Executive Officer | |
New York State Bar Association
![]() New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
RBC Europe Ltd. (Broker)
![]() RBC Europe Ltd. (Broker) Investment Banks/BrokersFinance RBC Europe Ltd. is the Great Britain-based broker/dealer subsidiary of RBC Europe Ltd., itself a subsidiary of Royal Bank of Canada (TSE: RY) in Canada. Headquartered in London, the firm was founded in 1970 and provides a full spectrum of brokerage services specifically tailored for both retail and institutional investors. The firm is active in several markets, exchanges, and electronic trading platforms. | Investment Banks/Brokers | Analyst-Equity | |
Natixis Investment Managers SA
![]() Natixis Investment Managers SA Investment ManagersFinance Natixis Investment Managers SA provides asset management services. The company was founded on June 18, 2004 and is headquartered in Paris, France. | Investment Managers | Chief Executive Officer | |
SFR GROUP | Major Telecommunications | Director of Finance/CFO | |
Labcorp International Group Ltd.
![]() Labcorp International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Chiltern International Group Ltd. operates as a holding company with interests in providing clinical development and other outsourced services to the pharmaceutical, medical device and biotechnology industries. The company was founded on May 23, 2006 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
FIERA CAPITAL CORPORATION | Investment Managers | Director/Board Member | |
Stevenage Bioscience Catalyst
![]() Stevenage Bioscience Catalyst BiotechnologyHealth Technology Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman | |
Investec Bank Plc (Broker)
![]() Investec Bank Plc (Broker) Investment Banks/BrokersFinance Investec Bank Plc (Broker) (IBP) is the brokerage arm of Investec Bank Plc, itself a subsidiary of Investec Plc (LON: INVP) in Great Britain. Headquartered in London, IBP was founded in 1950 and they offer a full spectrum of brokerage services specifically tailored for corporate clients. | Investment Banks/Brokers | Analyst-Equity | |
CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Director of Finance/CFO | |
Natixis Global Asset Management SA /Fund Distributor/
![]() Natixis Global Asset Management SA /Fund Distributor/ Investment Banks/BrokersFinance Part of BPCE SA, Natixis Global Asset Management SA /Fund Distributor/ provides fund management services. The company is based in Paris, France. Jean Raby has been the CEO of the French company since 2017. | Investment Banks/Brokers | Chief Executive Officer | |
Agency For Science Technology & Research Ventures
![]() Agency For Science Technology & Research Ventures Investment ManagersFinance Agency For Science Technology & Research Ventures is a Venture Capital firm, a subsidiary of Agency for Science, Technology & Research founded in 1991 with headquartered in Singapore. | Investment Managers | Private Equity Investor | |
The Sainsbury Laboratory
![]() The Sainsbury Laboratory Medical/Nursing ServicesHealth Services The Sainsbury Laboratory is a plant and microbial research company based in Norwich, UK. The British company has confirmed funding for the development of a plant and microbial science and innovation hub. The private company has recently gained insight into pathogen suppression of plant immune receptor networks, which delivers exciting innovation for disease resistance. The company has also published research on Phytophthora sojae and Pseudomonas syringae pv. tomato DC3000 extracellular vesicles. The company will be present at the Royal Norfolk Show in 2023. The company was founded in 1987. | Medical/Nursing Services | Chairman | |
Harvard Law School | College/University | Graduate Degree | |
Clinigen SP Ltd.
![]() Clinigen SP Ltd. Pharmaceuticals: MajorHealth Technology Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million. | Pharmaceuticals: Major | Director/Board Member | |
Brainomix Ltd.
![]() Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
BenevolentAI Ltd.
![]() BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Packaged Software | Chairman Director/Board Member Founder Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
MODERNA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member Investor Relations Contact | |
Tech Nation Group Ltd. | Investment Managers | Chief Executive Officer Director/Board Member | |
BenevolentAI Technology Ltd.
![]() BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Technology Ltd. is a leading, clinical-stage AI-enabled drug discovery and British development company. Founded in 2005, the company is based in London, UK. From target identification through to clinical development, their AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success. The company uses AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug. The company uses machine learning to generate new insights into the underlying causes of disease and capture these insights in their knowledge graph to support drug discovery and development. In 2022, they refined and formalized their approach to sustainability, under the direction of the newly established environmental, social and governance (ESG) governance structure and teams. | Packaged Software | Director/Board Member Director/Board Member | |
Idis Group Holdings Ltd.
![]() Idis Group Holdings Ltd. MiscellaneousMiscellaneous Part of Triley Bidco Ltd., Idis Group Holdings Ltd. is a holding British company. The company is based in Burton-on-Trent, UK. Founded in 2005, Idis Group Holdings operates as a holding company. | Miscellaneous | Director/Board Member | |
Clinigen Holdings Ltd.
![]() Clinigen Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Clinigen Holdings Ltd. develops pharmaceutical products. The company is based in Burton-on-Trent, UK. Clinigen Holdings was founded in 2017. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United Kingdom | 24 |
United States | 10 |
Canada | 9 |
France | 7 |
Singapore | 3 |
Sectoral
Finance | 13 |
Health Technology | 9 |
Commercial Services | 9 |
Consumer Services | 9 |
Miscellaneous | 6 |
Operational
Director/Board Member | 96 |
Corporate Officer/Principal | 42 |
Independent Dir/Board Member | 26 |
Chief Executive Officer | 26 |
Chairman | 15 |
Most connected contacts
Insiders | |
---|---|
Francois Nader | 28 |
Jean Raby | 25 |
Olivier Brandicourt | 23 |
Joanna Shields | 19 |
Ann Hunter | 16 |
Nigel Shadbolt | 13 |
John Orloff | 13 |
Martin Gouldstone | 12 |
Nicholas Keher | 11 |
Michael Brennan | 9 |
Susan Liautaud | 9 |
Marcello Damiani | 8 |
Ivan Griffin | 8 |
Robert Quinn | 7 |
Anne Phelan | 6 |
- Stock Market
- Insiders
- Kenneth Mulvany
- Company connections